SGLT2 Inhibitors versus Sulfonylureas as Add-On Therapy to Metformin in Type 2 Diabetes: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Umer, Muhammed
Salman, Ali
Nadeem, Shahrukh
Iqbal, Abiha
Tashrifwala, Fatema
Paryani, Neha Saleem
Ali, Eman
Kumar, Jai
Maniya, Muhammad Talha
Asad, Dayab
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Diabetes (Type II);
D O I：
10.1161/circ.148.suppl_1.14623
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14623
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis
    Liu, Jiali
    Li, Ling
    Li, Sheyu
    Jia, Pengli
    Deng, Ke
    Chen, Wenwen
    Sun, Xin
    SCIENTIFIC REPORTS, 2017, 7
  • [32] SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
    Huilin Tang
    Qi Dai
    Weilong Shi
    Suodi Zhai
    Yiqing Song
    Jiali Han
    Diabetologia, 2017, 60 : 1862 - 1872
  • [33] Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
    Wen-Hsuan Tsai
    Shih-Ming Chuang
    Sung-Chen Liu
    Chun-Chuan Lee
    Ming-Nan Chien
    Ching-Hsiang Leung
    Shu-Jung Liu
    Hong-Mou Shih
    Scientific Reports, 11
  • [34] DPP4 INHIBITORS COMPARED TO SULFONYLUREAS AS ADD-ON THERAPY TO METFORMIN AND RISK OF FRACTURES IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Azharuddin, M.
    Adil, M.
    Ghosh, P.
    Kapur, P.
    Sharma, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S526 - S527
  • [35] The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis
    Chen, Jiao
    Fan, Fang
    Wang, J. Y.
    Long, Yang
    Gao, C. L.
    Stanton, R. C.
    Xu, Yong
    SCIENTIFIC REPORTS, 2017, 7
  • [36] The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis
    Jiao Chen
    Fang Fan
    J. Y. Wang
    Yang Long
    C. L. Gao
    R. C. Stanton
    Yong Xu
    Scientific Reports, 7
  • [37] Efficacy and safety of combination therapy with SGLT2 and DPP4 inhibitors in the treatment of type 2 diabetes: A systematic review and meta-analysis
    Cho, Y. K.
    Kang, Y. M.
    Lee, S. E.
    Lee, J.
    Park, J. -Y.
    Lee, W. J.
    Kim, Y. -J.
    Jung, C. H.
    DIABETES & METABOLISM, 2018, 44 (05) : 393 - 401
  • [38] SGLT2 inhibitors as add on therapy in type 2 diabetes: A real world study
    Tamez-Perez H.E.
    Delgadillo-Esteban E.
    Soni-Duque D.
    Hernández-Coria M.I.
    Tamez-Peña A.L.
    Journal of Diabetes & Metabolic Disorders, 16 (1):
  • [39] Risk of fracture associated with SGLT-2 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes mellitus
    Yang, Hyeri
    Choi, Eunmi
    Kim, Bonggi
    Chung, Soo Youn
    Han, Soon Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 329 - 329
  • [40] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Wen-jie Li
    Xing-qing Chen
    Ling-ling Xu
    Yuan-qing Li
    Bi-hui Luo
    Cardiovascular Diabetology, 19
12345